Qube Research & Technologies Ltd

Position in RVMD — Revolution Medicines, Inc.

CIK 1729829 LONDON, X0

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$53,807,452

+$24,889,887 QoQ

Shares Held

553,290

-29.6% QoQ

Ownership

0.260%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. RVMD ranks #7 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc. This page	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$53,807,452	553,290	-29.6%	Shares	Sole	2026-05-15
2025-06-30	$28,917,565	786,017	+329.2%	Shares	Sole	2025-08-14
2025-03-31	$6,475,830	183,140	-20.7%	Shares	Sole	2025-05-15
2024-12-31	$10,097,160	230,845	+61.3%	Shares	Sole	2025-02-14
2024-09-30	$6,488,405	143,074	-42.6%	Shares	Sole	2024-11-14
2024-06-30	$9,670,985	249,188	+48.8%	Shares	Sole	2024-08-14
2024-03-31	$5,397,879	167,480	+556.4%	Shares	Sole	2024-05-14
2023-12-31	$731,769	25,515	-88.3%	Shares	Sole	2024-02-13
2023-09-30	$6,046,197	218,432	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.